Cytosorbents (CTSO) Q3 2024 Earnings Report
CH:CTSO Q3 2024 EPS Results
- Actual EPS
- -CHF 0.66
- Consensus EPS
- -CHF 1.04
- Beat/Miss
- Beat by +CHF 0.38
- One Year Ago EPS
- -CHF 3.46
CH:CTSO Q3 2024 Revenue Results
- Actual Revenue
- CHF 7.74M
- Expected Revenue
- CHF 8.38M
- Beat/Miss
- Missed by -CHF 647.22K
- YoY Revenue Growth
- +6.58%
Earnings Announcement Details
- Quarter
- Q3 2024
- Date
- 11/07/2024
- Time
- After Close
- Conference Call
- Thursday, November 7, 2024
CH:CTSO Upcoming Earnings
Cytosorbents's next earnings date is estimated for November 12, 2026, based on past reporting schedules.
Q3 2024 Earnings Call Audio
CH:CTSO Q3 2024 Earnings Call
0:00 / 0:00
Q3 2024 Earnings Slide Deck
Q3 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
CH:CTSO Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 12, 2026 | 2026 (Q3) | -0.74- | -0.66 | ― | ― |
| Aug 06, 2026 | 2026 (Q2) | -0.74-1.15 | 0.49 | -333.33% (-1.65) | |
| May 13, 2026 | 2026 (Q1) | -0.91-0.82 | -0.33 | -150.00% (-0.49) | |
| Mar 25, 2026 | 2025 (Q4) | -0.82-1.48 | -2.31 | 35.71% (+0.82) | |
| Nov 13, 2025 | 2025 (Q3) | -0.66-0.66 | -0.66 | 0.00% (+0.00) | |
| Aug 07, 2025 | 2025 (Q2) | -0.930.49 | -1.32 | 137.50% (+1.81) | |
| May 14, 2025 | 2025 (Q1) | ―-0.02 | -1.98 | 99.17% (+1.96) | |
| Mar 31, 2025 | 2024 (Q4) | -1.15-0.33 | -1.98 | 83.33% (+1.65) | |
| Nov 07, 2024 | 2024 (Q3) | -1.04-0.66 | -3.46 | 80.95% (+2.80) | |
| Aug 13, 2024 | 2024 (Q2) | -1.61-1.32 | -2.31 | 42.86% (+0.99) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed